Evidence map›Paper›PMID 35708168›Full record

ArticleEuropean heart journal2022

Functional stress imaging to predict abnormal coronary fractional flow reserve: the PACIFIC 2 study.

Roel S Driessen, Pepijn A van Diemen, Pieter G Raijmakers, Juhani Knuuti, Teemu Maaniitty, S Richard Underwood, Eike Nagel, Lourens F H J Robbers, Ahmet Demirkiran, Martin B von Bartheld and 8 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in European heart journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07371247 (Based on ctDNA-MRD Guided Adjuvant Treatment Escalation After Definitive Chemoradiotherapy for Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma), which is not on this map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
8.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07371247 early_phase1enrolling by invitationnot on this mapstarted 2025, after this paper: background citation

Based on ctDNA-MRD Guided Adjuvant Treatment Escalation After Definitive Chemoradiotherapy for Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma: a Study on Safety and Efficacy

TypeinterventionalSponsorThe First Affiliated Hospital with Nanjing Medical UniversityRan2025 to 2027Enrolled65ConditionsEsophageal Cancer, MRD, ctDNAArmsStep-up therapy, Standard treatment Routine treatment
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 62 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Stress CMR versus SPECT for the detection of coronary artery disease: meta-analysis and implications for the German healthcare.Clinical research in cardiology : official journal of the German Cardiac Society · 2026
    Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Myocardial perfusion imaging in advanced coronary artery disease.European journal of clinical investigation · 2025
    Review
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2023
    Article
  15. Article
  16. Article
  17. Review
  18. Role of cardiac imaging in management of heart failure.The Korean journal of internal medicine · 2023
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 4 countries.

Roel S DriessenDepartment of Cardiology, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.ORCID 0000-0003-3971-0109
Pepijn A van DiemenDepartment of Cardiology, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.
Pieter G RaijmakersDepartment of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.
Juhani KnuutiDepartment of Clinical Physiology, Nuclear Medicine and PET and Turku PET Centre, Turku University Hospital, Kiinamyllynkatu 4-8, FI-20520 Turku, Finland.
Teemu MaaniittyDepartment of Clinical Physiology, Nuclear Medicine and PET and Turku PET Centre, Turku University Hospital, Kiinamyllynkatu 4-8, FI-20520 Turku, Finland.ORCID 0000-0001-5819-4635
S Richard UnderwoodDepartment of Nuclear Medicine, Royal Brompton Hospital, Sydney St, London SW3 6NP, UK.ORCID 0000-0002-5777-1442
Eike NagelInstitute for Experimental and Translational Cardiovascular Imaging, University Hospital Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany.ORCID 0000-0002-6044-950X
Lourens F H J RobbersDepartment of Cardiology, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.ORCID 0000-0002-8826-7628
Ahmet DemirkiranDepartment of Cardiology, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.ORCID 0000-0001-8104-3296
Martin B von BartheldDepartment of Cardiology, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.ORCID 0000-0002-8618-2858
Peter M van de VenDepartment of Epidemiology and Biostatistics, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.
Leonard HofstraDepartment of Cardiology, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.
G Aernout SomsenDepartment of Cardiology, Cardiology Centers of the Netherlands, 1073 TB Amsterdam, The Netherlands.
Igor I TulevskiDepartment of Cardiology, Cardiology Centers of the Netherlands, 1073 TB Amsterdam, The Netherlands.
Ronald BoellaardDepartment of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.
Albert C van RossumDepartment of Cardiology, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.ORCID 0000-0003-1714-4652
Ibrahim DanadDepartment of Cardiology, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.
Paul KnaapenDepartment of Cardiology, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.
Amsterdam University Medical Centers · NLTurku University Hospital · FIGoethe University Frankfurt · DERoyal Brompton Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsThe diagnostic performance of non-invasive imaging in patients with prior coronary artery disease (CAD) has not been tested in prospective head-to-head comparative studies. The aim of this study was to compare the diagnostic performance of qualitative single-photon emission computed tomography (SPECT), quantitative positron emission tomography (PET), and qualitative magnetic resonance imaging (MRI) in patients with a prior myocardial infarction (MI) or percutaneous coronary intervention (PCI). METHODS AND

resultsIn this prospective clinical study, all patients with prior MI and/or PCI and new symptoms of ischaemic CAD underwent 99mTc-tetrofosmin SPECT, [15O]H2O PET, and MRI, followed by invasive coronary angiography with fractional flow reserve (FFR) in all coronary arteries. All modalities were interpreted by core laboratories. Haemodynamically significant CAD was defined by at least one coronary artery with an FFR ≤0.80. Among the 189 enrolled patients, 63% had significant CAD. Sensitivity was 67% (95% confidence interval 58-76%) for SPECT, 81% (72-87%) for PET, and 66% (56-75%) for MRI. Specificity was 61% (48-72%) for SPECT, 65% (53-76%) for PET, and 62% (49-74%) for MRI. Sensitivity of PET was higher than SPECT (P = 0.016) and MRI (P = 0.014), whereas specificity did not differ among the modalities. Diagnostic accuracy for PET (75%, 68-81%) did not statistically differ from SPECT (65%, 58-72%, P = 0.03) and MRI (64%, 57-72%, P = 0.052). Using FFR < 0.75 as a reference, accuracies increased to 69% (SPECT), 79% (PET), and 71% (MRI).

conclusionIn this prospective head-to-head comparative study, SPECT, PET, and MRI did not show a significantly different accuracy for diagnosing FFR defined significant CAD in patients with prior PCI and/or MI. Overall diagnostic performances, however, were discouraging and the additive value of non-invasive imaging in this high-risk population is questionable.

Indexed as

Coronary Artery DiseaseFractional Flow Reserve, MyocardialMyocardial Perfusion ImagingPercutaneous Coronary InterventionCoronary AngiographyHumansPredictive Value of TestsProspective StudiesTomography, X-Ray ComputedChronic coronary syndromeFractional flow reserveMagnetic resonance imagingPositron emission tomographySingle-photon emission computed tomography

Identifiers

PMID35708168
PMCPMC9433308
OpenAlexW4283026980

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.